Environmental Risk Factors Influence the Natural History of Familial Dilated Cardiomyopathy

Stacey Peters,Leah Wright,Jessica Yao,Lauren McCall,Tina Thompson,Bryony Thompson,Renee Johnson,Quan Huynh,Celine Santiago,Alison Trainer,Mark Perrin,Paul James,Dominica Zentner,Jonathan M Kalman,Thomas H. Marwick,Diane Fatkin

DOI: https://doi.org/10.1101/2024.06.25.24309501

2024-06-26

Abstract:Background Familial dilated cardiomyopathy (DCM) is characterized by marked variability in phenotypic penetrance. The extent to which this is determined by patient-specific environmental factors is unknown. Methods A retrospective longitudinal cohort study was performed in families with DCM-causing genetic variants. Environmental factors were classified into two subsets based on evidence for a causal link to depressed myocardial contractility, termed (1) DCM-promoting factors and (2) heart failure (HF) comorbidities. These factors were correlated with DCM diagnosis, disease trajectory, and adverse events. Results 105 probands and family members were recruited: 51 genotype-positive, phenotype-positive (G+P+), 24 genotype-positive, phenotype-negative (G+P-), and 30 genotype-negative, phenotype-negative (G-P-). Baseline characteristics were similar between the 3 genotype groups. DCM-promoting environmental factors (eg. alcohol excess) were enriched in G+P+ individuals compared to G+P- (P<0.001) and G-P- (P=0.003) and were significantly associated with age at DCM onset (HR 2.01, P=0.014). HF comorbidities (eg. Diabetes) had a similar prevalence in G+P+ and G-P- but were significantly reduced in the G+P- group. Fluctuations in left ventricular ejection fraction during follow-up were linked to changes in environmental factors in 35/45 (78%) of instances: 32 (91%) of these were DCM-promoting factors. HF comorbidities, but not DCM-promoting factors, were associated with adverse events in G+ individuals (OR 4.9, P=0.004). Conclusion We identified distinct subsets of environmental factors that affect DCM penetrance and adverse outcomes respectively. Our data highlight DCM-promoting environmental factors as key determinants of penetrance and disease trajectory. Collectively, these findings provide a new framework for risk factor assessment in familial DCM and have important implications for clinical management.

Cardiovascular Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how environmental risk factors affect the natural course and clinical manifestations of Familial Dilated Cardiomyopathy (DCM). Specifically, the study aims to answer the following questions:

1. **Influence of environmental factors on DCM**: Which environmental risk factors are associated with the onset, disease progression, and adverse events of DCM? How do these factors affect the disease manifestations of individuals carrying pathogenic gene variants?

2. **Differences among individuals with different genotypes**: Among individuals carrying DCM - pathogenic gene variants, are there differences in the influence of environmental risk factors on different genotypes (such as TTN truncating variants)?

3. **Mechanism of action of environmental factors**: Can environmental factors reversibly change left ventricular function within a specific time window? This provides a new perspective for the clinical management and risk assessment of DCM.

### Research background

Dilated cardiomyopathy (DCM) is an important heart muscle disease, characterized by significant phenotypic penetrance variation. Although genetic variants are known to play an important role in the onset of DCM, the specific impact of patient - specific environmental factors on this phenotypic variation remains unclear. Therefore, researchers hope to better understand the natural course of DCM and the diversity of its clinical manifestations by analyzing environmental risk factors.

### Research methods

The researchers conducted a retrospective longitudinal cohort study, including family members with DCM - pathogenic gene variants. Environmental risk factors were divided into two categories:
- **DCM - promoting factors**: Factors that directly lead to a decline in myocardial contractile function, such as excessive alcohol consumption, drug abuse, etc.
- **Heart failure comorbidity factors**: Comorbidities related to heart failure, such as hypertension, diabetes, etc.

By analyzing the associations between these factors and DCM diagnosis, disease trajectory, and adverse events, the researchers hope to reveal the role of environmental factors in DCM.

### Main findings

1. **Relationship between DCM - promoting factors and disease occurrence**: DCM - promoting factors were more common in gene - positive and phenotype - positive individuals (G+P+), and were significantly associated with the age of DCM onset (HR 2.01, P = 0.014).

2. **Relationship between heart failure comorbidity factors and adverse events**: Heart failure comorbidity factors were similar in G+P+ and G - P - individuals, but were significantly reduced in G+P - individuals. Heart failure comorbidity factors were significantly associated with the occurrence of adverse events (OR 4.9, P = 0.004), while DCM - promoting factors were not.

3. **Relationship between left ventricular ejection fraction (LVEF) fluctuations and environmental factors**: 78% of LVEF fluctuations could be attributed to changes in environmental factors, of which 91% were caused by DCM - promoting factors.

### Conclusion

This study shows that environmental risk factors play a crucial role in the penetrance and disease trajectory of familial DCM. In particular, DCM - promoting factors significantly affect the onset time and severity of the disease, while heart failure comorbidity factors are closely related to adverse events. These findings provide a new framework for the risk assessment and clinical management of DCM, emphasizing the importance of monitoring and managing environmental risk factors.